Anzeige
Mehr »
Login
Samstag, 28.05.2022 Börsentäglich über 12.000 News von 666 internationalen Medien

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von BioPharma-Reporter

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
Fr4D Pharma reveals progress in phase 2 trial of live biotherapeutic candidate in bladder cancer
FrMerck KGaA launches largest single investment in manufacturing
FrHanmi expands offerings with 'high-tech' CDMO services
MiInceptor Bio generates $37m in funding round as it advances CAR-T platform into the clinic
MiLithuanian CDMO to open facility in Boston
DiLonza to lend manufacturing expertise and knowledge to Israeli biotechs
MoLonza houses bioconjugation facility for Kodiak
MoBD and Mitsubishi partner to create 'next-gen' syringe
19.05.Can Sernova and Evotec's cell therapy approach result in a functional cure for diabetes?
19.05.WHO validates 11th COVID-19 vaccine
19.05.Bacteriophage producer Locus Biosciences raises $35m in financing
19.05.AGC Biologics adds new viral vector suspension capabilities at US cell & gene facility
17.05.Korea's Lotte plans to scale its biologics CDMO business in North America as it buys BMS site
17.05.AbbVie and Cugene ink autoimmune therapy partnership
17.05.RQ Bio launches to develop therapies based on broad-spectrum mAbs
17.05.BeiGene opens regional office in Basel to strengthen European presence
16.05.Survey puts spotlight on US neurologists' response to CMS Alzheimer drugs decision
16.05.Novartis looks to work more strategically as CDMO
16.05.EU sets out intention to terminate COVID-19 vaccine deal with Valneva
16.05.Gerresheimer ramps up glass and plastic production capacities in India
12.05.Lonza secures deal with ALSA Ventures to support its portfolio of biotechs
12.05.What are the benefits of oral delivery of insulin and how can algae support candidate therapeutic proteins?
12.05.Bora Pharmaceuticals acquires Eden Biologics, as it continues to expand its CDMO focus
12.05.What are the benefits or oral delivery of insulin and how can algae support candidate therapeutic proteins?
10.05.FDA outlines benefit-risk approach to drug or biologic product quality assessment